MDi is pleased to announce the successful closure of a further round of funding.

£2.3 million has been made available by current investors Avlar Bioventures and YFM. MDi received the first tranche of £1.175 during September bringing the total raised to date to c£6m.

The additional funding enables the company to expand its activities in the acquisition of intellectual property and the management and development of interventional medical devices.

Current innovations
An image of two surgeons

MDi's latest innovations...
Case Studies and details on MDi's latest projects.

Our commitment
An image of an experiment

MDi: our commitment to you...
MDi is the first medical device development and IP management company to be established in Europe.